Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-025070
Filing Date
2024-10-15
Accepted
2024-10-15 07:57:33
Documents
1
Period of Report
2024-10-10

Document Format Files

Seq Description Document Type Size
1 form4-10152024_111030.html 4  
1 form4-10152024_111030.xml 4 12789
  Complete submission text file 0001415889-24-025070.txt   14386
Mailing Address 3621 SOUTH STATE ST 695 KMS PL ANN ARBOR MI 48108
Business Address
MAYLEBEN TIMOTHY M (Reporting) CIK: 0001242613 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 241369322

Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)